Nepal secures Rs 8.59 billion in vaccine support through 2030
Summary
Nepal has secured Rs 8.59 billion in vaccine support from Gavi through 2030, boosting the country’s routine immunisation programme. Gavi has also waived a US$308,271 repayment linked to audit findings on earlier funding use.
Key Points
- Nepal has secured Rs 8.59 billion in vaccine support from Gavi, the Vaccine Alliance, through 2030.
- Gavi has waived a US$308,271 repayment after an audit found procedural shortcomings in the use of routine immunisation funds.
- The funding will help sustain vaccination services and protect children and other target groups from infectious diseases.
- Health officials say the support will strengthen the financial sustainability and management of Nepal’s immunisation programme.
